Clarity Pharmaceuticals Ltd - Asset Resilience Ratio

Latest as of June 2025: 65.08%

Clarity Pharmaceuticals Ltd (CU6) has an Asset Resilience Ratio of 65.08% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Clarity Pharmaceuticals Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

AU$65.84 Million

≈ $46.59 Million USD Cash + Short-term Investments

Total Assets

AU$101.17 Million

≈ $71.59 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Clarity Pharmaceuticals Ltd's Asset Resilience Ratio has changed over time. See what is Clarity Pharmaceuticals Ltd's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Clarity Pharmaceuticals Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Clarity Pharmaceuticals Ltd market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$29.41 Million	29.07%
Short-term Investments	AU$36.43 Million	36.01%
Total Liquid Assets	AU$65.84 Million	65.08%

Asset Resilience Insights

Very High Liquidity: Clarity Pharmaceuticals Ltd maintains exceptional liquid asset reserves at 65.08% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Clarity Pharmaceuticals Ltd Industry Peers by Asset Resilience Ratio

Compare Clarity Pharmaceuticals Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	3.28%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Argen-X F:1AE	Biotechnology	25.67%
Zhejiang Ausun Pharmaceutical Co Ltd SHG:603229	Biotechnology	0.21%
R&G PharmaStudies Co. Ltd. A SHE:301333	Biotechnology	35.96%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.48%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	70.49%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%

Annual Asset Resilience Ratio for Clarity Pharmaceuticals Ltd (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Clarity Pharmaceuticals Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	65.08%	AU$65.84 Million ≈ $46.59 Million	AU$101.17 Million ≈ $71.59 Million	-2.05pp
2024-06-30	67.13%	AU$103.80 Million ≈ $73.45 Million	AU$154.63 Million ≈ $109.41 Million	-9.65pp
2023-06-30	76.78%	AU$59.04 Million ≈ $41.77 Million	AU$76.90 Million ≈ $54.41 Million	+14.67pp
2022-06-30	62.11%	AU$62.00 Million ≈ $43.87 Million	AU$99.82 Million ≈ $70.63 Million	+15.68pp
2021-06-30	46.43%	AU$10.50 Million ≈ $7.43 Million	AU$22.61 Million ≈ $16.00 Million	+35.46pp
2020-06-30	10.97%	AU$1.00 Million ≈ $707.56K	AU$9.12 Million ≈ $6.45 Million	-32.67pp
2019-06-30	43.65%	AU$4.52 Million ≈ $3.20 Million	AU$10.36 Million ≈ $7.33 Million	--

pp = percentage points

About Clarity Pharmaceuticals Ltd

AU:CU6 Australia Biotechnology

Market Cap

$763.38 Million

AU$1.08 Billion AUD

Market Cap Rank

#10389 Global

#258 in Australia

Share Price

AU$2.90

Change (1 day)

+2.47%

52-Week Range

AU$1.90 - AU$5.70

All Time High

AU$8.79